Literature DB >> 22370093

Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.

Akshaya K Meher1, Poonam R Sharma, Vitor A Lira, Masayuki Yamamoto, Thomas W Kensler, Zhen Yan, Norbert Leitinger.   

Abstract

Activation of the transcription factor NF-E2-related factor 2 (Nrf2) by oxidative stress induces the expression of a variety of antioxidant and anti-inflammatory genes. Yet, genetic ablation of Nrf2 was shown to protect mice from high-fat diet (HFD)-induced obesity and insulin resistance. The mechanisms that underlie this seemingly paradoxical finding remain largely unexplored. Here we examined whether Nrf2 deficiency in myeloid cells contributes to protection against HFD-induced metabolic changes by decreasing adipose tissue inflammation. In vitro, induction of IL-1β by inflammatory stimuli was significantly reduced in Nrf2-deficient macrophages. Whereas inflammatory gene expression in the stromal vascular fraction was reduced in both global and chimeric Nrf2 KO mice, only global Nrf2-deficient, and not bone marrow-transplanted Nrf2 chimeric, mice were protected against HFD-induced adipose tissue inflammation. Whereas global Nrf2 deficiency resulted in significantly decreased expression of inflammatory genes and PPARγ2, there was no difference when Nrf2 was absent only from myeloid cells. In vitro coculture with adipocytes demonstrated that macrophage Nrf2 regulated inflammatory gene expression in macrophages; however, it was not required to induce inflammatory gene expression in adipocytes. Finally, in contrast to global Nrf2 knockout, Nrf2 deficiency in myeloid cells did not protect against HFD-induced insulin resistance. Together, our data demonstrate a dominant role for nonmyeloid Nrf2 in controlling HFD-induced adipose tissue inflammation and the development of insulin resistance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370093      PMCID: PMC3383807          DOI: 10.1016/j.freeradbiomed.2012.02.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  38 in total

Review 1.  Regulatory mechanisms of cellular response to oxidative stress.

Authors:  K Itoh; T Ishii; N Wakabayashi; M Yamamoto
Journal:  Free Radic Res       Date:  1999-10

2.  Differential effects of DNA tumor virus nuclear oncogene products on adipocyte differentiation.

Authors:  K Tobe; M Kasuga; H Kitasato; F Takaku; T Takano; K Segawa
Journal:  FEBS Lett       Date:  1987-05-11       Impact factor: 4.124

3.  Intracellular thiol redox status of macrophages directs the Th1 skewing in thioredoxin transgenic mice during aging.

Authors:  Yukie Murata; Michiko Amao; Junya Yoneda; Junji Hamuro
Journal:  Mol Immunol       Date:  2002-02       Impact factor: 4.407

4.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

5.  Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.

Authors:  Airu Chen; Sheena Mumick; Chunsheng Zhang; John Lamb; Hongyue Dai; Drew Weingarth; John Mudgett; Howard Chen; Douglas J MacNeil; Marc L Reitman; Su Qian
Journal:  Obes Res       Date:  2005-08

6.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.

Authors:  Rajesh K Thimmulappa; Hannah Lee; Tirumalai Rangasamy; Sekhar P Reddy; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.

Authors:  Mie Mochizuki; Yukio Ishii; Ken Itoh; Takashi Iizuka; Yuko Morishima; Toru Kimura; Takumi Kiwamoto; Yosuke Matsuno; Ahamed E Hegab; Akihiro Nomura; Tohru Sakamoto; Koji Uchida; Masayuki Yamamoto; Kiyohisa Sekizawa
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

8.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes.

Authors:  S C Frost; M D Lane
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

10.  Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.

Authors:  Dionysios V Chartoumpekis; Panos G Ziros; Agathoklis I Psyrogiannis; Athanasios G Papavassiliou; Venetsana E Kyriazopoulou; Gerasimos P Sykiotis; Ioannis G Habeos
Journal:  Diabetes       Date:  2011-08-18       Impact factor: 9.461

View more
  28 in total

1.  Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

Authors:  Alan R Collins; Anisha A Gupte; Ruirui Ji; Maricela R Ramirez; Laurie J Minze; Joey Z Liu; Magda Arredondo; Yuelan Ren; Tuo Deng; Jun Wang; Christopher J Lyon; Willa A Hsueh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

Review 2.  The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.

Authors:  Zhiguo Zhang; Shanshan Zhou; Xin Jiang; Yue-Hui Wang; Fengsheng Li; Yong-Gang Wang; Yang Zheng; Lu Cai
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 3.  The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.

Authors:  Vlad Serbulea; Dory DeWeese; Norbert Leitinger
Journal:  Free Radic Biol Med       Date:  2017-02-21       Impact factor: 7.376

4.  The Keap1-Nrf2 system prevents onset of diabetes mellitus.

Authors:  Akira Uruno; Yuki Furusawa; Yoko Yagishita; Toshiaki Fukutomi; Hiroyuki Muramatsu; Takaaki Negishi; Akira Sugawara; Thomas W Kensler; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

Review 5.  Emerging role of Nrf2 in adipocytes and adipose biology.

Authors:  Kevin S Schneider; Jefferson Y Chan
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

Review 6.  Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.

Authors:  Anisha A Gupte; Christopher J Lyon; Willa A Hsueh
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

7.  Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice.

Authors:  Dionysios V Chartoumpekis; Dushani L Palliyaguru; Nobunao Wakabayashi; Marco Fazzari; Nicholas K H Khoo; Francisco J Schopfer; Ian Sipula; Yoko Yagishita; George K Michalopoulos; Robert M O'Doherty; Thomas W Kensler
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-02-27       Impact factor: 4.310

8.  Obesity increases cerebrocortical reactive oxygen species and impairs brain function.

Authors:  Linnea R Freeman; Le Zhang; Anand Nair; Kalavathi Dasuri; Joseph Francis; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2012-10-29       Impact factor: 7.376

Review 9.  Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.

Authors:  Liang Xu; Naoto Nagata; Tsuguhito Ota
Journal:  Adipocyte       Date:  2018-08-09       Impact factor: 4.534

10.  Nuclear factor erythroid 2-related factor 2 activation mediates hyperhomocysteinemia-associated lipolysis suppression in adipocytes.

Authors:  Xin Li; Yuhong Cheng; Xiuli Zhong; Bing Zhang; Zhiwei Bao; Yi Zhang; Zhigang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.